Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 44Pancreatic Neoplasms 17Stomach Neoplasms 16Neoplasm Metastasis 11Rectal Neoplasms 10Neoplasms 10Colonic Neoplasms 7Adenocarcinoma 7Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Esophageal Neoplasms 4Cholangiocarcinoma 4Burkitt Lymphoma 4Advanced Solid Tumors 4Adenocarcinoma Of Esophagus 4Leukemia, Biphenotypic, Acute 3Esophageal Squamous Cell Carcinoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Locally Recurrent Rectal Cancer 2Gallbladder Neoplasms 2Endometrial Neoplasms 2Appendiceal Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1

Interventions

dolutegravir 1Tenofovir 1Oxaliplatin 1Leucovorin 1Ketotifen 1Fluorouracil 1Bestrophins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neuritis × Leucovorin × Clear all
NCT05624138 2025-05-11

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

Tanta University

Phase 3 Recruiting
64 enrolled

Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡